Kozenis TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tafenoquine
Brand name
(ARTG)
: KOZENIS tafenoquine 150 mg film-coated tablet blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Tafenoquine is indicated, in combination with chloroquine, for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria (see Section 4.2 DOSE AND METHOD OF ADMINISTRATION).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- Tafenoquine tablets are pink film-coated, capsule-shaped tablets, plain on one side and debossed with 'GS J11' on the other side.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 2 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tafenoquine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
